Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Chromosome Region Associated with Increased Risk for Melanoma

By Labmedica staff writers
Posted on 27 May 2008
Scientists have identified a region on chromosome 20 (20q11.22) that influences a person's risk of developing melanoma.

Prolonged exposure to the suns harmful ultraviolet (UV) rays can lead to melanoma, the deadliest form of skin cancer. More...
An unanswered question, however, is why some people are more prone to develop melanoma than others are.

A team of investigators from the Translational Genomic Research Institute (TGen; Phoenix, AZ, USA) and the Queensland Institute of Medical Research (QIMR; Queensland, Australia) is close to discovering a new gene that could help explain variation in melanoma risk. The scientists narrowed the gene location through a genome-wide association study--a first in melanoma research. The study--whose data collection began 20 years ago--involved more than 4,000 Australian samples (2,019 cases and 2,105 controls) and was a joint project between Australian, American, and European research groups.

A genome-wide association study involves scanning the DNA from two sets of individuals: those with a particular disease (cases) and those of similar individuals without the disease (controls). The DNA of each sample is then examined for strategically selected markers of genetic variation, called single nucleotide polymorphisms (SNPs). If certain genetic variations are found to be significantly more frequent in people with the disease compared to people without disease, those variations are said to be "associated” with the disease. The associated genetic variations can serve as roadmaps to the region of the human genome where the disease-causing gene resides.

Dr. Kevin Brown, TGen investigator commented, "We're closing in on genetic variants which cause 16% of the population to be at nearly double the increased risk of developing the disease. In public health terms, this finding is highly significant.”


Related Links:
The Translational Genomic Research Institute
Queensland Institute of Medical Research

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.